Tasty Morsels of Critical Care 039 | Management of raised ICP

3 May

Welcome back to the tasty morsels of critical care podcast.

This is part of Oh’s Manual Chapter 77 on head injury and we covered ICP monitoring before in number 20.

A key principle here is cerebral perfusion pressure or CPP. This is easily calculated at the bedside as MAP-ICP. Of course this is only easy if you actually have an ICP monitor.  The CPP should probably be around 60-70 which assuming your patient is unconscious means that the ICP is probably north of 20mmHg and therefore your MAP should be around the 80-90mmHg range. If you actually have a monitor then you can be much more scientific about your MAP target. A moment’s thought about the complexities and unknowns of cerebral blood flow and perfusion in the acutely head injured patient should hopefully make you realise that targeting a CPP is an incredibly blunt tool for so fine tuned an instrument, but given the lack of anything better and strong recommendations from international guidelines then we better stick to it.

Oh splits TBI into two phases which I find useful as a concept even if I still find it unclear when a patient transitions from one phase to the next.

  1. the early hypo-perfusion phase: after a bump to the noggin there is a rise in pressure from extra axial lesions or oedema that necessitates a bump in your MAP to keep CPP in the right range.
  2. the hyperaemic phase: about a quarter will have this at around day 3-7 and it seems ill defined but it’s suggestive you can lower your MAP targets here a bit

Overall the basic bundle of interventions in the ICU for ICP include:

  • sedation – this is needed for the tube but also it reduces metabolic rate considerably and reduces ICP. There is no clear advantage of one agent over another although the ileus inducing agent thiopentone is useful in refractory settings
  • SUP – this is one of the groups particularly at risk of GI bleeding
  • keeping the head up 30-40 degrees can promote venous drainage and indeed you’ll see ET tubes taped to the cheeks rather than circumferential ties in many neurosurgical units.
  • DVT prophylaxis should be given – the timing of which is a topic in itself and frequently delayed longer than it should be. The phrase used typically is when the appearances on CT are “stable” whatever that means but it probably does include the absence of fresh bleeding at the very least.
  • CO2 should be in the normal range and same goes for oxygenation. Now is not the time for permissive hypercapnoea and so for your patients with head injury and ARDS this can be really challenging

The BTF guidance is the key guideline document that should be referenced and it is well worth a read for any exam candidate and indeed any clinician dealing with TBI. The following summarises some of the headlines.

Decompressive craniectomy

  • a bifrontal cranitoyomy is not recommended to improve neuro outcomes, which is a way of acknowledging the important DECRA trial.
  • if done then a large frontotemporal craniectomy is recommended
  • of note these were published before the results of the RESCUE-ICP were available

Hypothermia

  • there is a substantial literature and a compelling physiologic argument that cooling would be good
  • however a sequence of trials have put this to rest with the key ones being
    • Eurotherm 2015
      • RCT ICP>20, 400 pts
      • small impact on ICPs
    • POLAR 2018
      • 500 pts RCT
      • no difference, again little impact on ICP also. There was a decent increase in pneumonia here.

Hyperosmolar

  • mannitol effective controlling high ICP but reserve it for those who look like they are near herniating
  • importantly they have no recommendation on hypertonic saline. Doesn’t mean it doesn’t work just that not enough data yet to sell it over mannitol

CSF Drainage

  • an EVD can be useful to drain CSF (and lower pressure) in the early period

Steroids

  • no, no and no again…

Seizure prophylaxis

  • not recommended for preventing late epilepsy (which is an obscure answer to a question no one asked as we use it typically to prevent early seizures)
  • phenytoin is recommended to reduce early (within 1 week) seizures when “benefit outweighs risk” (though early seizures not shown to worsen outcomes)
  • not enough evidence to recommend keppra over phenytoin but you can guess what happens in real life

Tagged onto the end of this post on ICP management I’ve included recommendations from a separate BTF guidance that covers when to operate on TBI. In reality this should maybe have been covered first as managing an expanding extradural with mannitol and thio is doing it all wrong. These particular guidelines can be printed out and rolled up and used as a stick to beat your neurosurgeons into operating. But i jest.

SDH

  • clot >10 mm, >5mm shift, regardless of GCS
  • those with less severe numbers but low GCS or unequal/fixed pupils should also get surgery

EDH

  • Conservative: <30cm3, <15mm depth, <5mm shift and GCS>8
  • Surgical: all >30cm3 should be evacuated.

Parenchymal TBI

  • any >50cm3
  • >20cm3 and shift >5mm with GCS 6-8

Posterior fossa

  • most of these get evacuated (due to mass effect or reduced GCS)

Depressed fractures

  • open and depressed >thickness of the skull generally get surgery (though not all)

In reality I find this guidance is viewed somewhat loosely by our neurosurgical colleagues and given the level of evidence it’s based on they may well be right but we do run into the usual neurocrit care dilemma of self fulfilling prophecy.  Managing these patients with medical therapy when they should have had surgery inevitably results in bad outcomes.

In closing, I realise I have neglected to mention the 3 tiered approach to ICP management where you provide therapies in a step wise fashion but alas i have ran over time already.

References:

Oh’s Manual 77

BTF Guidance

BTF Surgical Guidance

 

 

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.